The American Brain Tumor Association offers free, hour-long monthly webinars on topics of interest to brain tumor patients, families, and health care professionals. Webinars are recorded and can be viewed later at your convenience. If you can't attend an upcoming live webinar session, please register by clicking on the link at the bottom of each webinar description to receive a link to the recorded webinar afterwards.
Please note: The webinar times listed below are in Central Time. Please check your time zone to adjust for this accordingly. In addition, when you visit any of the registration links below, you can click on "Show in My Time Zone" below the webinar's title to confirm the time for your location.
Beyond the Standard of Care: The Role of Clinical Trials, Tuesday, December 6, 12:00pm - 1:00pm CST
Research studies, or clinical trials, are used to develop new treatments for brain tumors. They are particularly important to brain tumor patients because they may offer treatment options that would otherwise not be available. However, less than 10 percent of brain tumor patients actually enroll in a clinical trial, primarily due to lack of awareness. While participation in a clinical trial may not be appropriate for everyone, patients and their families often find it empowering to research their options and talk with their doctor about clinical trials. Join Julian Bailes, MD, Chairman of Neurosurgery and Ryan Merrell, MD, Director, Neuro-Oncology Program, NorthShore Neurological Institute, who will present an overview of what patients need to know about clinical trials. They will focus on who should consider trials, the various trial phases and what patients can expect including those required to have surgery in advance of participation. They will share the latest in surgical technologies and techniques and will discuss clinical trials focused on immunotherapy treatments as well as other clinical trials being offered for brain tumor patients, including a new clinical trial for patients with recurrent glioblastoma or anaplastic astrocytoma that involves a virus-based cancer-selective gene therapy. Webinar participants will have the opportunity to ask questions in an interactive question and answer session. Please make sure to enter a valid email when registering for this webinar to ensure you receive any additional information about the session. Following the live webinar, all registrants will receive a link to the webinar recording.
Click here to register for the Beyond the Standard of Care: The Role of Clinical Trials webinar.
Laser Interstitial Thermal Therapy (LITT): An Emerging Therapy for Brain Tumors on Tuesday, January 17, 1:00pm - 2:00pm CST
A brain lesion is caused by injured tissue or disease in the brain, such as a brain tumor. For some patients with brain lesions, surgical methods and medicines may not be enough as an effective treatment. Laser interstitial thermal therapy (LITT) is a new emerging therapy that uses heat to treat brain lesions. This new technology has already been used in more than 3,000 patients in the U.S. and Canada. Learn more about LITT in the ABTA’s free educational webinar presented by Paul J. Camarata, MD, University of Kansas Medical Center, who will discuss how the emerging procedure works, when it may be an appropriate choice for patients, and what results one can expect after LITT. Webinar participants will have the opportunity to ask questions in an interactive question and answer session. This webinar is sponsored by Monteris Medical. Please make sure to enter a valid email when registering for this webinar to ensure you receive any additional information about the session. Following the live webinar, all registrants will receive a link to the webinar recording.
Click here to register for the Laser Interstitial Thermal Therapy (LITT): An Emerging Therapy for Brain Tumors webinar.
To view any of our past webinars, which feature a variety of brain tumor related topics, visit our Anytime Learning webpage. You can also click here to register to receive periodic updates and communications via email from ABTA, and be first to hear about our upcoming webinars as well as other programs we offer.